Cantel Medical Authorizes Semiannual Dividend

Share Name	Share Symbol	Market	Type
Cantel Medical Corp.	NYSE:CMN	NYSE	Common Stock

Share Name

Share Symbol

Market

Type

Cantel Medical Corp.

NYSE:CMN

NYSE

Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	81.14				0	01:00:00

Price Change

% Change

Share Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

81.14

01:00:00

Cantel Medical Authorizes Semiannual Dividend

17/12/2009 3:56pm

PR Newswire (US)

Cantel (NYSE:CMN)
Historical Stock Chart

From Jun 2019 to Jun 2024

LITTLE FALLS, N.J., Dec. 17 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that its Board of Directors intends to pay, for the first time, a semiannual cash dividend of $0.05 per outstanding share, or $0.10 per share annually, on the Company's common stock. The Board declared the first cash dividend of $0.05 per share of outstanding common stock, to be paid on January 29, 2010 to shareholders of record at the close of business on January 15, 2010. Future declaration of semiannual dividends and the establishment of future record and payment dates are subject to the final determination of the Company's Board of Directors. Andrew A. Krakauer, President and CEO, stated, "The Board of Directors believes that it is in the best interests of the Company's shareholders to commence the payment of regular semiannual cash dividends. Our new dividend policy reflects the sustained strength of our financial performance and our outstanding cash flow generation and balance sheet." Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com/. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated. DATASOURCE: Cantel Medical Corp. CONTACT: Andrew A. Krakauer, President & CEO, Cantel Medical Corp., +1-973-890-7220; Richard E. Moyer, Cameron Associates, Inc., +1-212-554-5466, Web Site: http://www.cantelmedical.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CMN Cantel Medical Corp.